开云app官网登录入口网页版-官方正版

#NICU#

9篇内容 | 994人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1590727, encodeId=ce4f1590e2755, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Lancet Haematol：与NICU的重症新生儿动静脉血栓形成相关的风险因素！, objectType=article, longId=295443, objectId=60452954435e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60452954435e, replyNumber=0, likeNumber=63, createdTime=2022-02-12, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60452954435e, moduleTitle=Lancet Haematol：与NICU的重症新生儿动静脉血栓形成相关的风险因素！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60452954435e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590726, encodeId=8fe91590e2655, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Immunicum AB宣布其DC细胞疗法Ilixadencel与CTLA-4免疫检查点抑制剂联合使用的阳性临床前数据, objectType=article, longId=181706, objectId=bec5181e0657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bec5181e0657, replyNumber=0, likeNumber=104, createdTime=2019-10-23, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bec5181e0657, moduleTitle=Immunicum AB宣布其DC细胞疗法Ilixadencel与CTLA-4免疫检查点抑制剂联合使用的阳性临床前数据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bec5181e0657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590725, encodeId=8c171590e25c7, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Immunicum的DC细胞疗法ilixadencel联合舒尼替尼成功治疗转移性肾癌, objectType=article, longId=178534, objectId=2f721e8534aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f721e8534aa, replyNumber=0, likeNumber=67, createdTime=2019-09-03, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f721e8534aa, moduleTitle=Immunicum的DC细胞疗法ilixadencel联合舒尼替尼成功治疗转移性肾癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2f721e8534aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590724, encodeId=787f1590e2425, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Lancet Child Adol Health:抗菌剂浸渍的中央静脉导管对NICU患儿感染风险的影响, objectType=article, longId=165232, objectId=912f165232a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=912f165232a4, replyNumber=0, likeNumber=53, createdTime=2019-05-02, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=912f165232a4, moduleTitle=Lancet Child Adol Health:抗菌剂浸渍的中央静脉导管对NICU患儿感染风险的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=912f165232a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590723, encodeId=a1101590e2324, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Crit Care Med：减少NICU中不必要的抗生素使用不妨先定个“小目标”, objectType=article, longId=159922, objectId=0a6915992223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6915992223, replyNumber=0, likeNumber=80, createdTime=2019-02-15, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6915992223, moduleTitle=Crit Care Med：减少NICU中不必要的抗生素使用不妨先定个“小目标”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a6915992223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590722, encodeId=13701590e2267, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Am J Obstet Gynecol：先兆子痫高风险孕妇阿司匹林能减少小宝宝的NICU时间？, objectType=article, longId=142253, objectId=8c961422536e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c961422536e, replyNumber=0, likeNumber=65, createdTime=2018-07-04, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c961422536e, moduleTitle=Am J Obstet Gynecol：先兆子痫高风险孕妇阿司匹林能减少小宝宝的NICU时间？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8c961422536e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590721, encodeId=758d1590e2170, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=World J Pediatr：搬迁与环境清洁对降低NICU医疗保健相关感染发病率的影响, objectType=article, longId=132931, objectId=6ea61329316f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea61329316f, replyNumber=0, likeNumber=48, createdTime=2018-03-21, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea61329316f, moduleTitle=World J Pediatr：搬迁与环境清洁对降低NICU医疗保健相关感染发病率的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6ea61329316f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590720, encodeId=8bb51590e207d, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？, objectType=article, longId=124793, objectId=fa96124e9321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa96124e9321, replyNumber=0, likeNumber=66, createdTime=2017-12-28, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa96124e9321, moduleTitle=Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fa96124e9321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1590719, encodeId=e96d1590e1974, content=<a href='/topic/show?id=9e7c12e9608' target=_blank style='color:#2F92EE;'>#NICU#</a>, objectTitle=WIRB-Copernicus Group收购Vigilare International, objectType=article, longId=121769, objectId=aa64121e697b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa64121e697b, replyNumber=0, likeNumber=64, createdTime=2017-12-01, rootId=0, userName=zhangjiqing, userId=cd9917855235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa64121e697b, moduleTitle=WIRB-Copernicus Group收购Vigilare International, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aa64121e697b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

NICU

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Lancet Haematol：与NICU的重症新生儿动静脉血栓形成相关的风险因素！

2022-02-12

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Immunicum AB宣布其DC细胞疗法Ilixadencel与CTLA-4免疫检查点抑制剂联合使用的阳性临床前数据

2019-10-23

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Immunicum的DC细胞疗法ilixadencel联合舒尼替尼成功治疗转移性肾癌

2019-09-03

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Lancet Child Adol Health:抗菌剂浸渍的中央静脉导管对NICU患儿感染风险的影响

2019-05-02

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Crit Care Med：减少NICU中不必要的抗生素使用不妨先定个“小目标”

2019-02-15

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Am J Obstet Gynecol：先兆子痫高风险孕妇阿司匹林能减少小宝宝的NICU时间？

2018-07-04

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

World J Pediatr：搬迁与环境清洁对降低NICU医疗保健相关感染发病率的影响

2018-03-21

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？

2017-12-28

zhangjiqing (审核中...)

前往app查看评论内容

#NICU#

WIRB-Copernicus Group收购Vigilare International

2017-12-01

科室
- - 订阅+
  - 更多科室
工具
服务